CTI BioPharma Corp.
(NASDAQ : CTIC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-0.15%177.890.4%$133.60m
PRGOPerrigo Co. Plc
0.52%73.376.8%$97.43m
JAZZJazz Pharmaceuticals Plc
1.40%164.202.2%$72.31m
MNKMallinckrodt Plc
-0.19%29.7421.1%$71.03m
ENDPEndo International Plc
0.82%16.078.9%$59.62m
PTLAPortola Pharmaceuticals, Inc.
1.10%28.577.7%$39.73m
UTHRUnited Therapeutics Corporation
1.10%127.5914.4%$39.39m
SAGESAGE Therapeutics, Inc.
-0.47%146.279.6%$37.30m
GWPHGW Pharmaceuticals PLC Sponsored ADR
5.33%157.156.8%$36.40m
CTLTCatalent Inc
0.32%43.022.4%$36.18m
ICPTIntercept Pharmaceuticals, Inc.
0.44%121.1318.7%$32.31m
ZGNXZogenix, Inc.
-1.64%47.8511.9%$28.92m
SUPNSupernus Pharmaceuticals, Inc.
0.96%47.356.2%$28.11m
MDCOMedicines Company
0.30%33.7621.8%$24.93m
PCRXPacira Pharmaceuticals, Inc.
4.28%49.9010.6%$24.58m

Company Profile

CTI BioPharma Corp. operates as a biopharmaceutical company, which focuses on the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. Its products include PIXUVRI, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.